T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis

Citations Over TimeTop 1% of 2010 papers

Abstract

Autologous T lymphocytes genetically engineered to express a murine T cell receptor (TCR) against human carcinoembryonic antigen (CEA) were administered to three patients with metastatic colorectal cancer refractory to standard treatments. All patients experienced profound decreases in serum CEA levels (74-99%), and one patient had an objective regression of cancer metastatic to the lung and liver. However, a severe transient inflammatory colitis that represented a dose limiting toxicity was induced in all three patients. This report represents the first example of objective regression of metastatic colorectal cancer mediated by adoptive T cell transfer and illustrates the successful use of a TCR, raised in human leukocyte antigen (HLA) transgenic mice, against a human tumor associated antigen. It also emphasizes the destructive power of small numbers of highly avid T cells and the limitations of using CEA as a target for cancer immunotherapy.

Related Papers

• → High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer(2001)89 cited
• Elevated carcinoembryonic antigen (CEA) levels in a patient with no malignancy.(2000)
• The use of serial carcinoembryonic antigen determinations to predict recurrence of carcinoma of the colon and the time for a second-look operation.(1978)
• [Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer].(1998)
• Relationship of intestinal obstruction to serial plasma carcinoembryonic antigen levels.(1980)